Ashima Bhatia
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 8
-
- Pneumonia and Respiratory Infections 7
- Co-authors
- Ravindra Yeole (6 shared papers)Mark H. Gotfried (3 shared papers)Keith A. Rodvold (3 shared papers)H. David Friedland (4 shared papers)Mahesh Kumar Mittal (1 shared paper)Sunita Saxena (1 shared paper)JP Singh (1 shared paper)Anju Bansal (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (6 papers)Journal of Drug Delivery Science and Technology (1 paper)Drug Design Development and Therapy (1 paper)Clinical and Translational Science (1 paper)AAPS PharmSciTech (1 paper)
- Partner nations
- IndiaUnited StatesNepal
In The Last Decade
Ashima Bhatia
21 papers receiving 361 citations
Peers
Comparison fields: 5 of 73
- Molecular Medicine 92
- Applied Microbiology and Biotechnology 27
- Pharmacology 102
- Rehabilitation 27
- Clinical Biochemistry 22
Countries citing papers authored by Ashima Bhatia
This map shows the geographic impact of Ashima Bhatia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashima Bhatia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashima Bhatia more than expected).
Fields of papers citing papers by Ashima Bhatia
This network shows the impact of papers produced by Ashima Bhatia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashima Bhatia. The network helps show where Ashima Bhatia may publish in the future.
Co-authors
The 25 scholars most cited alongside Ashima Bhatia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 65 | |
| 2 | 2005 | 63 | |
| 3 | 2019 | 53 | |
| 4 | 2018 | 34 | |
| 5 | 2018 | 31 | |
| 6 | 2017 | 29 | |
| 7 | 2017 | 18 | |
| 8 | 2018 | 13 | |
| 9 | 2018 | 12 | |
| 10 | 2019 | 11 | |
| 11 | 2019 | 8 | |
| 12 | 2024 | 7 | |
| 13 | 2005 | 7 | |
| 14 | 2023 | 5 | |
| 15 | 2022 | 4 | |
| 16 | Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy. | 2003 | 4 |
| 17 | 2021 | 3 | |
| 18 | 2025 | 2 | |
| 19 | 2022 | 2 | |
| 20 | Efficacy & tolerability of ondansetron compared to metoclopramide in dose dependent cisplatin-induced delayed emesis. | 2004 | 2 |
About Ashima Bhatia
Ashima Bhatia is a scholar working on Pharmacology, Epidemiology, Molecular Medicine, Surgery and Infectious Diseases, having authored 22 papers that have together received 375 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Pneumonia and Respiratory Infections (7 papers), Antibiotic Resistance in Bacteria (6 papers), Nausea and vomiting management (2 papers), Crystallization and Solubility Studies (2 papers), Cardiac electrophysiology and arrhythmias (1 paper), Patient Safety and Medication Errors (1 paper) and Dermatologic Treatments and Research (1 paper). The work is most often cited by research in Molecular Medicine (92 citations), Applied Microbiology and Biotechnology (27 citations), Pharmacology (102 citations), Rehabilitation (27 citations) and Clinical Biochemistry (22 citations). Ashima Bhatia has collaborated with scholars based in India, United States and Nepal. Frequent co-authors include Ravindra Yeole, Mark H. Gotfried, Keith A. Rodvold, H. David Friedland, Mahesh Kumar Mittal, Sunita Saxena, JP Singh, Anju Bansal, Chintamani Chintamani and Prasad Deshpande. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Drug Delivery Science and Technology, Drug Design Development and Therapy, Clinical and Translational Science and AAPS PharmSciTech.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.